Ozempic added to anti-doping watchlist

WADA prohibited list
Athletes will be banned from using tramadol in-competition from 1 January 2024, with Ozempic (semaglutide) being added to the WADA “monitoring list”  Use of diabetes treatment, Ozempic, by athletes is set to come under the World Anti-Doping Agency’s (WADA’s) microscope under the organisation’s updated prohibited list.  The new WADA Prohibited List was approved by the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Incident reporting 101
Next Colloquium 2024 to amplify Indigenous voices